Serotonin Reuptake Inhibitors Vs. Tricyclics in Deficit syndrome of Schizophrenia

Saeed Shoja Shafti
Additional contact information
Saeed Shoja Shafti: Professor of Psychiatry, University of Social Welfare and Rehabilitation Sciences (USWR), Iran

Global Journal of Intellectual & Developmental Disabilities, 2018, vol. 5, issue 2, 22-26

Abstract: Negative symptoms are essential barricades against psychosocial rehabilitation in schizophrenia. In this regard a variety of adjunctive medications have been used in different studies for improvement of these symptoms. In the present study effectiveness of tricyclics (Clomipramine, Nortriptyline, Maprotiline) has been compared with serotonin reuptake inhibitors (Citalopram, Fluoxetine, Fluvoxamine) concerning amelioration of negative symptoms.

Keywords: Journal of Intellectual; Intellectual & Developmental; Intellectual & Developmental Disabilities; Journal of Intellectual & Developmental Disabilities; journal of intellectual disability research; journal of intellectual disabilities; journal of intellectual disability research impact factor; journal of intellectual property studies; open access publishers in usa; juniper publishers review (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjidd/pdf/GJIDD.MS.ID.555657.pdf (application/pdf)
https://juniperpublishers.com/gjidd/GJIDD.MS.ID.555657.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjidd:v:5:y:2018:i:2:p:22-26

DOI: 10.19080/GJIDD.2018.05.555657

Access Statistics for this article

Global Journal of Intellectual & Developmental Disabilities is currently edited by Sophia Mathis

More articles in Global Journal of Intellectual & Developmental Disabilities from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().